1.54 USD
0 (0%)
1.54 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 77% to LAB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.58. This target is 2.66% above the current price.
LAB was analyzed by 7 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about LAB.
In the previous month the buy percentage consensus was at a similar level.
LAB was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-05 | TD Cowen | Maintains | Hold -> Hold |
| 2025-02-27 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2024-10-31 | TD Cowen | Maintains | Buy -> Buy |
| 2024-08-01 | TD Cowen | Maintains | Buy -> Buy |
| 2024-04-16 | TD Cowen | Initiate | Buy |
| 2024-04-04 | Jefferies | Initiate | Buy |
| 2023-07-12 | Keybanc | Initiate | Overweight |
STANDARD BIOTOOLS INC / LAB FAQ
What is the average price target for STANDARD BIOTOOLS INC (LAB) stock?
7 analysts have analysed LAB and the average price target is 1.58 USD. This implies a price increase of 2.66% is expected in the next year compared to the current price of 1.54.
How do analysts rate STANDARD BIOTOOLS INC (LAB)?
The consensus rating for STANDARD BIOTOOLS INC (LAB) is 77.1429 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for STANDARD BIOTOOLS INC stock?
The number of analysts covering STANDARD BIOTOOLS INC (LAB) is 7.